Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abcellera Biologics Inc (NQ: ABCL ) 2.730 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Abcellera Biologics Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > AI Meets Biotech: 3 Top Stocks Transforming Medical Science December 16, 2023 The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week December 11, 2023 If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to... Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November December 06, 2023 The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 November 16, 2023 From AbCellera Biologics Inc. Via Business Wire Earnings Preview: AbCellera Biologics August 02, 2023 Via Benzinga AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023 November 03, 2023 From AbCellera Biologics Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Pre-Market Session November 03, 2023 Via Benzinga AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript November 03, 2023 ABCL earnings call for the period ending September 30, 2023. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Thursday's After-Market Session November 02, 2023 Via Benzinga AbCellera Reports Q3 2023 Business Results November 02, 2023 From AbCellera Biologics Inc. Via Business Wire Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology November 01, 2023 From AbCellera Biologics Inc. Via Business Wire Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology November 01, 2023 Multi-year collaboration to jointly discover, develop, and commercialize novel oncology medicines for up to five programs, with the first ADC program focusing on a SMARCA degrader From Prelude Therapeutics, Inc.; AbCellera Via GlobeNewswire AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023 October 31, 2023 From AbCellera Biologics Inc. Via Business Wire AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023 October 11, 2023 From AbCellera Biologics Inc. Via Business Wire AbCellera Announces Two T-Cell Engager Presentations at SITC 2023 September 27, 2023 From AbCellera Biologics Inc. Via Business Wire Argenx's 28% Surge & Promising Product Propel Investor Confidence September 25, 2023 Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target. Via MarketBeat AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron September 20, 2023 From AbCellera Biologics Inc. Via Business Wire AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology September 13, 2023 From AbCellera Biologics Inc. Via Business Wire Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects August 31, 2023 Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL), Via Benzinga 3 AI Stocks You’ll Regret Not Buying Soon August 08, 2023 AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in. Via InvestorPlace Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session August 04, 2023 Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. Via Benzinga Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session August 04, 2023 U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript August 04, 2023 ABCL earnings call for the period ending June 30, 2023. Via The Motley Fool 12 Health Care Stocks Moving In Thursday's After-Market Session August 03, 2023 Via Benzinga AbCellera Reports Q2 2023 Business Results August 03, 2023 From AbCellera Biologics Inc. Via Business Wire AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing July 24, 2023 From AbCellera Biologics Inc. Via Business Wire Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 12, 2023 Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. Via Benzinga InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday July 12, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom July 08, 2023 AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. Via InvestorPlace AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023 July 06, 2023 From AbCellera Biologics Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
